Paul T Grover

This inventor holds 17 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Sepracor, Inc., Sunovion Pharmaceuticals Inc., Astrazeneca Ab. Active years: 2000-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul T Grover. Retrieved from https://idiyas.com/inventor/paul-t-grover

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 4)

% Patents Active = 88.2

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 111(Granted Patents)

Location History:

Marlborough, MA (US) (2000 - 2002)
Franklin, MA (US) (2002 - 2006)
Plainville, MA (US) (2006 - 2014)
Waltham, MA (US) (2015 - 2016)

Company Filing History:

Sunovion Pharmaceuticals Inc.

Years Active: 2000-2016

Loading Chart...

Areas of Expertise:

Imidazo[1,2-a]Pyridine

Glucocorticoids

B2 Adrenergic Agonists

Anxiolytics

Tramadol Analogs

Stereoselective Process

Alkyl Phenylglycolic Acids

Asymmetric Grignard Synthesis

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9248140 - Chemical compounds (2016-02-02),

2. 9018381 - Chemical compounds (2015-04-28),

3. 8710036 - [object Object] (2014-04-29),

4. 8497278 - Imidazo[1,2-a]pyridine compounds (2013-07-30),

5. 8445470 - Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists (2013-05-21),

6. 7723324 - Imidazo[1,2-A]pyridine anxiolytics (2010-05-25),

7. 7566725 - Imidazo[1,2-A] pyridine anxiolytics (2009-07-28),

8. 7468362 - [object Object] (2008-12-23),

9. 7253156 - [object Object] (2007-08-07),

10. 7148353 - Imidazo[1,2-a] pyridine anxiolytics (2006-12-12),

11. 7018995 - Carbonate and carbamate modified forms of glucocorticoids (2006-03-28),

12. 6780891 - Tramadol analogs and uses thereof (2004-08-24),

13. 6376684 - Stereoselective process for alkyl phenylglycolic acids (2002-04-23),

14. 6337328 - Bupropion metabolites and methods of use (2002-01-08),

15. 6180823 - Stereoselective process for alkyl phenylglycolic acids (2001-01-30),

Title: The Innovative Contributions of Paul T. Grover

Introduction

Paul T. Grover, a notable inventor based in Franklin, Massachusetts, has made significant strides in the field of pharmaceutical chemistry, with a remarkable portfolio of 15 patents. His work primarily focuses on therapeutic compositions and novel chemical compounds that address various respiratory and inflammatory diseases.

Latest Patents

Among Grover's latest patents, one notable innovation involves compositions containing β-adrenergic agonists in combination with carbonates and carbamates. These compositions are crucial for treating bronchospasm, inducing bronchodilation, and addressing conditions such as rhinitis, asthma, chronic obstructive pulmonary disease (COPD), and other inflammatory diseases, particularly through inhalation methods. Another of his recent patents discloses Imidazo[1,2-a]pyridine compounds, which serve as useful therapeutic agents. These compounds, represented by a specific generic formula, are included in pharmaceutical formulations and are intended for various treatment methods.

Career Highlights

Throughout his career, Paul has worked with prominent companies such as Sepracor, Inc. and Sunovion Pharmaceuticals Inc., where he has contributed to the advancement of innovative health solutions. His extensive experience in the pharmaceutical industry reflects his commitment to improving patient outcomes through his inventions.

Collaborations

Paul T. Grover has collaborated with esteemed colleagues, including Chris Hugh Senanayake and Q Kevin Fang. These partnerships have bolstered his research endeavors, leading to meaningful developments in therapeutic applications and innovative pharmaceutical solutions.

Conclusion

In summary, Paul T. Grover's extensive patent portfolio and collaborative efforts highlight his significant contributions to pharmaceutical innovations. His work continues to impact the field, addressing critical health issues and exemplifying the importance of inventors in advancing medical science.

Profile summary based on public USPTO records.